Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
A stiff pricre increase for the products and a sharp decrease in costs, that is what the new CEO will be focussing on, that is what the new CEO is likely to achieve. No point in producing world leading chip-wafers at a loss.
APH specializes in niche medicines, yet parts with a nich medicine to an operator who bumps up the price of that medicine
manyfold... Was APH unaware of the mal-intent of the operator?
No smoke without a fire....?
Surely the Investigators are not entirely stupid? APH defence surely would have been accepted if believable and correct?
Re my previous message, BXP Results (H-1 ) out today, just excellent!
Re my previous message, BXP H1-Results out today - nothing short of excellent!
Cheers,
ws
The share price should never have gone as low as what it did, there was no negative information to warrant the fall. Today's good news is even better than I expected, the rise today (21%) is fully warranted, indeed there is almost certainly more of a rise to come over the coming days/weeks, IMHO.
Off Topic
To my friends here, I hope you don't mind a reminder of BXP rosy future, but in case you have missed it, BXP is right now (RNS today) making a generic Version of Pfizer's Covid19 pil which reduces the risk of developing serious illness by 90%. It works for Omicron also. Pfizer charges in excess of $500 for a single course.
I like APH for a long term hold, quite steady and quite safe, IMHO.
P.S. To my friends here, have a look at Beximco Pharmaceuticals (BXP), right now making a generic version of the
Pfizer Covid19 pil, which reduces the chance of developing serious illness by 90%. I rather like that! Pfizwer charges in excess of $500 for a single course.
High time for the newly appointed CEO to get cracking! No need to lose money on currency nmovements, no need to sell
the highly specialised world leading wafers at low prices, just bump oup the prices by 10 % and hey presto: handsome profits.
I am sure the new CEO will take the hard nosed financial approach that has been so long lacking here. I shall hold onto my shares to enjoy the benefits that shall come from that.
Dogsy - Well observed, and a sensible view! But IQE needs not to be taken over to do well. All that is needed is
someone at the helm with a harder financial nose than the outgpoing CEO. Americans, by their nature, are fairly hardnosed
when it comes to making money.
Share price |(GDR) is still remarkably low when looking at the price BXP's shares are traded at on the Dhaka stock exchange.
The more we get to know BXP as a sound and progressive growth company the narrower the gap will become between the GDRs here and the share price on the Dhaka stock exchange. Both are entitled to the same dividend, Just no voting rights
for GDRs.